X

    XBiotech Inc (XBIT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.28
    +0.01 (+0.44%)

    Market Cap: $69.21M

    Last updated: Aug 31, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    45%(10/22)
    Avg Surprise
    +330.27%
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    		$-0.22N/AN/ABeat-266.7%
    Mar 26
    		$-0.18N/AN/ABeat+49.4%
    Dec 25
    		$-0.88$0.00N/AMiss-155.9%
    Sep 25
    		$-0.20$0.00N/AMiss-21.5%
    Jun 25
    		$-0.06$0.00N/AMiss+85.9%
    Mar 25
    		$-0.36N/AN/ABeat-8.7%
    Dec 24
    		$-0.34N/AN/ABeat-126.3%
    Sep 24
    		$-0.16N/AN/ABeat+32.0%
    Jun 24
    		$-0.43N/AN/ABeat-48.7%
    Mar 24
    		$-0.33N/AN/ABeat-152.7%
    Dec 23
    		$-0.15N/AN/ABeat-44.8%
    Sep 23
    		$-0.24N/AN/ABeat+42.4%
    Jun 23
    		$-0.29N/AN/ABeat+24.4%
    Mar 23
    		$-0.13N/AN/ABeat+27.8%
    Dec 22
    		$-0.11N/AN/ABeat-75.3%
    Sep 22
    		$-0.42N/AN/ABeat-281.8%
    Jun 22
    		$-0.38N/AN/ABeat-533.3%
    Mar 22
    		$-0.18N/AN/ABeat-200.0%
    Dec 21
    		$-0.06$0.02-400.00%Miss+0.0%
    Sep 21
    		$-0.11$0.03-466.67%Miss-22.2%
    Jun 21
    		$-0.06$0.03-300.00%Miss+31.0%
    Mar 21
    		$-0.06$0.04-250.00%Miss-200.0%
    Dec 20
    		$-0.06$0.04-250.00%Miss-100.4%
    Sep 20
    		$-0.09$0.04-325.00%Miss+40.0%
    Jun 20
    		$-0.09$0.04-317.50%Miss+45.6%
    Mar 20
    		$0.06$0.06+0.00%Beat+137.5%
    Dec 19
    		$14.59$-0.15+9826.67%Beat+8682.4%
    Sep 19
    		$-0.15$-0.15+0.00%Beat+53.1%
    Jun 19
    		$-0.16$-0.15-6.67%Miss+50.0%
    Mar 19
    		$-0.16$-0.16+0.00%Beat+50.0%
    Dec 18
    		$-0.17$-0.17+0.00%Beat+22.7%
    Sep 18
    		$-0.32$-0.14-128.57%Miss-77.8%
    Jun 18
    		$-0.32$-0.16-100.00%Miss+0.0%
    Mar 18
    		$-0.32$-0.11-190.91%Miss+0.0%
    Dec 17
    		$-0.22N/A+53.19%Beat+56.9%
    Sep 17
    		$-0.18N/A+61.70%Beat+52.6%
    Jun 17
    		$-0.32$-0.47+31.91%Beat-
    Mar 17
    		$-0.32$-0.47+31.91%Beat-
    Dec 16
    		$-0.51$-0.42-21.43%Miss-
    Sep 16
    		$-0.38$-0.46+17.39%Beat-

    Dividends

    Dividend Metrics

    Yield0.00%
    Annual/Share$0.00
    Frequency0
    No dividend payments in the selected period.

    Key Metrics

    Valuation
    P/E Ratio-1.54EV/EBITDA-1.60x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-29.90%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio33.15xQuick Ratio33.15x
    Trading Statistics
    Beta0.85Avg Volume26.86K
    52-Week High$3.4452-Week Low$2.09

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.29
    SMA 20$2.30
    SMA 50$2.30
    SMA 200$2.39
    EMA 10$2.29
    EMA 20$2.30
    EMA 50$2.31
    EMA 200$2.43

    MACD

    Line: -0.00Signal: 0.00Hist: -0.00

    ADX

    ADX: 19.2+DI: 12.3-DI: 13.0

    Aroon & PSAR

    Aroon Up52.0
    Aroon Down20.0
    PSAR$2.42

    Bollinger Bands

    Upper Band$2.39
    Lower Band$2.21
    %B Position772%(Upper)
    Band Width0.39

    RSI (14-Day)

    Neutral
    47.5

    Momentum Oscillators

    Stoch %K22.2
    Stoch %D26.4
    Williams %R-79.2
    ROC (10d)-1.3%
    Momentum-0.03
    CCI (20d)-61.2
    MFI (14d)37.0

    Volatility Measures

    ATR (14d)$0.06(2.8%)
    StdDev (20d)0.04
    Hist Vol32.5%(Moderate)

    Volume Flow

    VWAP$2.28
    OBV-1.2M
    AD Line-2.3M
    CMF (20d)0.064

    Volume Metrics

    Avg Vol (20d)27.6K
    Vol Ratio0.8x
    VWMA (20d)$2.31

    Pivot Points

    R3$2.37
    R2$2.34
    R1$2.31
    Pivot Point$2.28
    S1$2.25
    S2$2.22
    S3$2.19

    Advanced Oscillators

    TSI-0.77
    Ultimate Osc54.4
    KST8.24

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$2.62M$0
    Cost of Revenue$0$0$378,000$0$0$0N/A$0$0$0$434,000$0
    Gross Profit$0$0$-378,000$0$0$0N/A$0$0$0$2.19M$0
    Operating Expenses$6.15M$6.27M$29.75M$6.05M$6.34M$13.55M$8.75M$7.90M$14.97M$10.85M$8.59M$8.52M
    R&D$5.30M$5.21M$25.36M$5.08M$5.34M$11.62M$7.82M$7.13M$12.98M$9.82M$7.80M$7.55M
    SG&A$850,000$1.07M$4.40M$967,000$1.00M$1.93M$927,000$777,000$1.98M$1.03M$782,000$973,000
    Operating Income$-6,146,000$-6,274,000$-29,752,000$-6,047,000$-6,336,000$-13,550,000$-8,748,000$-7,904,000$-14,966,000$-10,853,000$-8,587,000$-8,520,000
    Interest Income$885,000$914,000$1.22M$1.43M$1.53M$1.42M$1.89M$2.17M$2.49M$2.46M$2.60M$2.53M
    Interest Expense$536,000$0$0$0$0$0$1.80M$0$0$0$0$0
    Income Before Tax$-6,682,000$-5,456,000$-26,816,000$-5,906,000$-1,728,000$-10,855,000$-10,549,000$-5,006,000$-13,031,000$-9,977,000$-4,733,000$-7,056,000
    Income Tax Expense$46,000$49,000$76,000$102,000$28,000$29,000$-41,000$9,000$-25,000$25,000$-172,000$308,000
    Net Income$-6,728,000$-5,505,000$-26,892,000$-6,008,000$-1,756,000$-10,884,000$-10,508,000$-5,015,000$-13,006,000$-10,002,000$-4,635,000$-7,364,000
    EBITDA$-7,265,000$-6,038,000$-27,656,000$-6,906,000$-2,819,000$-11,829,000$-12,002,000$-6,733,000$-15,085,000$-12,003,000$-6,903,000$-9,153,000
    EBIT$-7,567,000$-6,370,000$-28,034,000$-7,333,000$-3,258,000$-12,271,000$-12,441,000$-7,172,000$-15,520,000$-12,435,000$-7,337,000$-9,585,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about XBIT

    News

    XBiotech (NASDAQ:XBIT) Issues Quarterly Earnings Results, Misses Estimates By $0.25 EPS

    XBiotech (NASDAQ:XBIT) reported a quarterly loss of $0.22 per share, significantly missing analysts' consensus estimate of a $0.03 profit by $0.25. Following the announcement, XBIT shares fell by $0.13 to $2.33, nearing its 52-week low, and the company's market capitalization is approximately $71 million. Wall Street sentiment remains negative, with Weiss Ratings downgrading the stock to "sell (e+)" and the sole tracked analyst also rating it "Sell."

    MarketBeat•8/14/26•
    Bearish

    XBiotech: Q2 Earnings Snapshot

    This article is an earnings snapshot for XBiotech's Q2 performance. It is a placeholder without actual financial details, suggesting that the full earnings report would contain the relevant financial data.

    KVUE•8/13/26•
    Neutral

    XBiotech: Q2 Earnings Snapshot

    This article provides a snapshot of XBiotech's Q2 earnings. No specific financial details are available in the provided content, but it indicates a focus on quarterly performance reporting.

    10tv.com•8/13/26•
    Neutral

    XBiotech (NASDAQ: XBIT) trims R&D spend yet remains loss-making in Q2 2026

    XBiotech Inc. reported a Q2 2026 net loss of $6.7 million and a six-month net loss of $12.2 million, despite significantly reducing research and development and general and administrative expenses. The clinical-stage biopharmaceutical company does not anticipate generating revenue in 2026 and expects continued operating losses. However, XBiotech maintains a strong cash position of $109.5 million, which management believes will fund operations for at least 12 months and support ongoing Phase II clinical trials for its IL-1a-targeting antibodies.

    Stock Titan•8/13/26•
    Somewhat-Bearish

    XBiotech Inc (XBIT) Earnings Forecast: Future EPS & Revenue Growth Estimates

    This article provides an earnings forecast for XBiotech Inc (XBIT), focusing on future EPS and revenue growth estimates. As of August 9, 2026, the company's stock is trading at 2.275 USD, with a market cap of 69.36M. The forecast section includes details on EPS, Revenue, Net Profit, and EBIT projections, indicating areas of financial analysis for potential investors.

    TradingKey•8/10/26•
    Neutral

    Frequently Asked Questions About XBIT

    Does XBIT pay dividends?
    XBiotech Inc (XBIT) has a dividend payment track record. See the XBIT dividend history page for its current payment status, yield, and streaks.
    What is XBIT's market cap?
    XBiotech Inc (XBIT) has a market capitalization of $69.21M with a current stock price of $2.28.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In